Cancer Statistics 2024–2025 (US & Global)
Note: Information reflects 2025 standards. Sources include GLOBOCAN 2022, ACS Cancer Facts & Figures, SEER, WHO.
Global Cancer Statistics 2022/2024
Most Common Cancers Worldwide (2022 GLOBOCAN Data)
| Cancer Type | New Cases | % of All Cancers | Deaths | % of Deaths |
|---|---|---|---|---|
| Lung Cancer | 2,480,675 | 12.4% | 1,817,020 | 18.7% |
| Breast Cancer (Female) | 2,296,840 | 11.6% | 670,685 | 6.9% |
| Colorectal Cancer | 1,926,425 | 9.6% | 904,019 | 9.3% |
| Prostate Cancer | 1,467,854 | 7.3% | 397,430 | 4.1% |
| Stomach Cancer | 968,784 | 4.9% | 660,087 | 6.8% |
Source: GLOBOCAN 2022 (https://gco.iarc.who.int)
US Cancer Statistics 2024
Projected New Cases (2024)
- Total: 2,001,140 new cancer cases
- Males: 1,029,080 cases (51.4%)
- Females: 972,060 cases (48.6%)
Projected Deaths (2024)
- Total: 611,720 cancer deaths
- Males: 322,800 deaths (52.8%)
- Females: 288,920 deaths (47.2%)
Top 10 US Cancers by Percentage (2024)
| Rank | Cancer Type | New Cases | % of All Cases |
|---|---|---|---|
| 1 | Breast (Female) | ~310,720 | 15.5% |
| 2 | Prostate | ~299,010 | 14.9% |
| 3 | Lung & Bronchus | ~234,580 | 11.7% |
| 4 | Colon & Rectum | ~152,810 | 7.6% |
| 5 | Melanoma | ~100,640 | 5.0% |
| 6 | Bladder | ~83,190 | 4.2% |
| 7 | Non-Hodgkin Lymphoma | ~80,620 | 4.0% |
| 8 | Kidney & Renal Pelvis | ~81,800 | 4.1% |
| 9 | Endometrial | ~67,880 | 3.4% |
| 10 | Pancreas | ~66,440 | 3.3% |
Source: ACS Cancer Facts & Figures 2024 (https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2024-cancer-facts-figures.html)
Cancer Death Percentages by Type (US 2024)
| Cancer Type | Deaths | % of Cancer Deaths |
|---|---|---|
| Lung & Bronchus | ~125,070 | 20.4% |
| Colon & Rectum | ~53,010 | 8.7% |
| Pancreas | ~51,750 | 8.5% |
| Breast (Female) | ~42,250 | 6.9% |
| Prostate | ~35,250 | 5.8% |
| Liver & Intrahepatic | ~29,380 | 4.8% |
| Leukemia | ~24,300 | 4.0% |
| Non-Hodgkin Lymphoma | ~20,180 | 3.3% |
| Bladder | ~16,840 | 2.8% |
| Kidney | ~14,890 | 2.4% |
Source: ACS Cancer Facts & Figures 2024
Global Regional Variations (Age-Standardized Rates per 100,000)
Highest Cancer Incidence Rates
- Australia/New Zealand: 507.9 (men), 410.5 (women)
- Northern America: 481.4 (men), 380.6 (women)
- Western Europe: 463.8 (men), 355.8 (women)
- Northern Europe: 450.2 (men), 370.9 (women)
Lowest Cancer Incidence Rates
- Western Africa: 97.1 (men), 109.3 (women)
- Middle Africa: 108.6 (men), 123.7 (women)
- South-Central Asia: 105.1 (men), 103.3 (women)
Source: WHO Global Cancer Observatory (https://gco.iarc.fr)
Cancer by Development Level (HDI)
Cases by Human Development Index
- Very High HDI: 9,775,800 cases (49.0%)
- High HDI: 6,636,600 cases (33.2%)
- Medium HDI: 2,824,700 cases (14.2%)
- Low HDI: 727,700 cases (3.6%)
Deaths by Human Development Index
- Very High HDI: 4,221,300 deaths (43.4%)
- High HDI: 3,651,900 deaths (37.5%)
- Medium HDI: 1,463,300 deaths (15.0%)
- Low HDI: 400,300 deaths (4.1%)
Source: GLOBOCAN 2022
5-Year Survival Rates by Cancer Type
| Cancer Type | 5-Year Survival Rate |
|---|---|
| Thyroid | 98.3% |
| Prostate | 97.5% |
| Testicular | 95.2% |
| Melanoma (localized) | 99.4% |
| Breast (all stages) | 90.3% |
| Hodgkin Lymphoma | 88.3% |
| Kidney | 76.5% |
| Non-Hodgkin Lymphoma | 73.8% |
| Colorectal | 65.1% |
| Ovarian | 49.7% |
| Lung | 22.9% |
| Pancreas | 12.8% |
Sources: SEER / ACS (US)
Cancer in Children and Adolescents
Pediatric Cancer Distribution (Ages 0-19)
- Leukemia: 28% of childhood cancers
- Brain/CNS Tumors: 26% of childhood cancers
- Lymphomas: 8% of childhood cancers
- Neuroblastoma: 6% of childhood cancers
- Soft Tissue Sarcomas: 4% of childhood cancers
Source: SEER; ACS
Rising Cancer Incidence Trends (2015-2019)
Fastest Growing Cancer Types
- Prostate Cancer: +3.1% annually
- Liver Cancer (women): +2.8% annually
- Melanoma: +2.1% annually
- Kidney Cancer: +1.2% annually
- Breast Cancer: +0.6% annually
- Pancreatic Cancer: +0.9% annually
Source: ACS / SEER
Cancer Disparities by Race/Ethnicity (US)
Higher Death Rates in Black Americans
- Prostate Cancer: 2.2x higher than whites
- Stomach Cancer: 2.0x higher than whites
- Endometrial Cancer: 1.9x higher than whites
Higher Death Rates in Native Americans
- Liver Cancer: 2.3x higher than whites
- Stomach Cancer: 2.1x higher than whites
- Kidney Cancer: 1.8x higher than whites
Sources: ACS; CDC / SEER
Economic Impact (US)
- Total annual cost: ~$208 billion
- Direct medical costs: ~$87 billion (42%)
- Lost productivity: ~$121 billion (58%)
Source: ACS
Preventable Cancer Cases
Percentage of Cancers That Could Be Prevented
- Smoking-related: ~30% of cancer deaths
- Diet/obesity-related: ~20% of cancer cases
- Infection-related: ~15% of cancer cases
- Total potentially preventable: ~40% of all cancers
Sources: ACS; WHO
2050 Projections
- 2022: 20 million new cases
- 2050: 35 million new cases (+77% increase)
- Largest increases expected in:
- Low HDI countries: +142%
- Medium HDI countries: +99%
- High HDI countries: +42%
Sources: WHO / IARC (GLOBOCAN)
Key Statistics Summary
Global Cancer Reality (2022)
- 1 in 5 people develop cancer in their lifetime
- 1 in 9 men die from cancer
- 1 in 12 women die from cancer
- 53.5 million people living with cancer (within 5 years of diagnosis)
US Cancer Reality (2024)
- 1 in 2 men will develop cancer in their lifetime
- 1 in 3 women will develop cancer in their lifetime
- 67% of cancer patients survive 5+ years (all types combined)
References
- GLOBOCAN 2022 / WHO Global Cancer Observatory
- American Cancer Society Cancer Facts & Figures 2024–2025
- SEER Cancer Statistics (NCI)
- WHO / IARC publications